Royal Bank Of Canada Trevena Inc Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $20 - $12,500	-125 Reduced 11.11%	1,000 $0
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $2,009 - $5,024	-10,048 Reduced 89.93%	1,125 $0
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $10,225 - $15,712	-24,941 Reduced 69.06%	11,173 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $7,900 - $17,880	13,861 Added 62.29%	36,114 $21,000
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $11,024 - $16,884	9,932 Added 80.61%	22,253 $27,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $17,988 - $27,722	12,321 New	12,321 $21,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.